No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Healthcare Information Services
Ping An Healthcare and Technology Company Limited (PAHT), through its subsidiaries, operates a comprehensive online platform that delivers healthcare services across the People's Republic of China. Its core offerings encompass virtual medical consultations, facilitated hospital referrals and appointment scheduling, inpatient care coordination, and expert second opinions. PAHT also provides standardized consumer healthcare packages, integrating services from a network of medical institutions. Beyond services, the company offers a broad array of products, including pharmaceuticals, health supplements, medical devices, wellness items such as fitness equipment and personal care products, and other miscellaneous goods. Furthermore, PAHT engages users with health management and wellness interaction services, featuring various programs, interactive tools, activities, and personalized content. Its additional operations include medicine marketing, technology services, application development and maintenance, direct hospital and clinic services, and the management of an insurance agency. Established in 2014, Ping An Healthcare and Technology Company Limited maintains its headquarters in Shanghai, China.
www.pagd.netNo one on the platform currently holds 1833.HK.
No tracked institution reports a position in 1833.HK as of their last filing.
No one on the platform has traded 1833.HK yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 1.3% | — | — | — | ||
| Rev. Growth % | 13.7% | -4.5% | ||||
| Profit Margin % | 6.9% | -5.9% | -26.5% | |||
| Free Cash Flow Margin % | 7.2% | -6.5% | -18.7% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $5.0B | -6.6% | $0.14 | $0.09–$0.20 | — | 9 |
| 2027 | $5.5B | +8.5% | $0.19 | $0.08–$0.28 | — | 9 |
| 2028 | $6.0B | +9.8% | $0.25 | $0.10–$0.42 | — | 9 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 7 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-18 | $-0.17 | $0.12 | +166.0% |
| 2026-03-24 | $-0.30 | $0.26 | +186.5% |
| 2025-08-19 | $-0.26 | $0.08 | +129.6% |
| 2025-03-12 | $-0.26 | $0.02 | +109.1% |
| 2024-03-19 | $-0.08 | $-0.03 | +65.0% |
| 2023-08-24 | $-0.11 | $-0.09 | +20.7% |
| 2023-03-13 | $-0.19 | $-0.07 | +64.6% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 1833.HKPing An Healthcare and Technology Company Limited | $5.99 | -2.76% | $12.7B | — |
| 0512.HKGrand Pharmaceutical Group Limited | $4.91 | +0.51% | $17.2B | — |
| 0867.HKChina Medical System Holdings Limited | $10.90 | -2.07% | $26.5B | — |
| 1066.HKShandong Weigao Group Medical Polymer Company Limited | $3.17 | +0.00% | $14.1B | — |
| 1513.HKLivzon Pharmaceutical Group Inc. |
| $20.80 |
| -1.33% |
| $22.7B |
| — |
| 2096.HKSimcere Pharmaceutical Group Limited | $11.25 | -1.23% | $28.9B | — |
| 2252.HKShanghai MicroPort MedBot (Group) Co., Ltd. | $21.18 | +0.00% | $21.7B | — |
Source: Financial Modeling Prep · peers by sector/industry